<DOC>
	<DOCNO>NCT01828359</DOCNO>
	<brief_summary>The purpose study evaluate blood pressure lower effect amlodipine/losartan combination treatment losartan/Hydrochlorothiazide combination treatment patient essential hypertension uncontrolled losartan 100mg monotherapy .</brief_summary>
	<brief_title>The Efficacy Safety Study Anti-hypertension Combination Drug Patients Uncontrolled With Monotherapy .</brief_title>
	<detailed_description>- Quality assurance plan implement site monitoring , include data validation registry procedure Source data verification ass accuracy , completeness compare data external data source ( medical record paper case report form ) . - Data dictionary contains registry , include source variable , cod information ( MedDRA ver12.0 ) , normal range . - Statistical analysis perform use SAS® Version 9.2 , SAS institute , Cary , NC , USA</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>20 aged Patients blood pressure measure Visit 1 ; 90mmHg≤MSDBP mmHg antihypertensive drug , 95mmHg≤MSDBP mmHg antihypertensive drug Patients blood pressure measure Visit 2 90mmHg≤MSDBP mmHg ( nonresponder Losartan 100mg 4week treatment ) Patients high Blood pressure •≥ sitSBP 20mmHg ≥ sitDBP 10mmHg variation three measurement reference arm select Screening History hypersensitivity CCB , Angiotensin II receptor blocker Sulfonamide . Secondary hypertension suspect</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>